Telix Pharmaceuticals Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Cash used in financing activities reached the amount of $10,186,000 last year. Net change in cash is therefore $6,908,000.
Cash Flow
| 2015 | -3.51M | -323.64K | 3.70M |
|---|---|---|---|
| 2017 | -1.05M | -1.00M | 2.23M |
| 2019 | -6.15M | -597.74K | 6.42M |
| 2022 | 0 | -16.99M | 174.96M |
| 2023 | 0 | -25.48M | 10.18M |
TLX Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|
Cash at beginning of period | 116.32M | 22.03M | 2.30M | 787.63K | 891.39K |
Operating activities | |||||
Net income | 0 | 0 | -1.99M | -3.70M | -2.39M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 0 | 0 | 1.61M | 1.69M | 3.39M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | -25.55K | -779.83K | -746.02K |
Inventories | 0 | 0 | 26.97K | -352.22K | -89.13K |
Accounts payable | 0 | 0 | -3.95M | 1.67M | -807.73K |
Cash generated by operating activities | 0 | 0 | -6.15M | -1.05M | -3.51M |
Investing activities | |||||
Purchases Of Investments | -13.15M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -10.79M | -13.86M | -535.26K | -246.94K | -239.99K |
Acquisitions Net | 0 | -973K | 0 | 0 | 0 |
Cash generated by investing activities | -25.48M | -16.99M | -597.74K | -1.00M | -323.64K |
Financing activities | |||||
Common Stock Issued | 6.65M | 181.03M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -7.81M | -759.6K | 0 | -750.14K |
Repayments of term debt | 5.75M | 0 | 0 | 0 | 0 |
Cash used in financing activities | 10.18M | 174.96M | 6.42M | 2.23M | 3.70M |
Net Change In Cash | 6.90M | 94.29M | -1.54M | 183.26K | -141.25K |
Cash at end of period | 123.23M | 116.32M | 759.6K | 970.89K | 750.14K |
| Data source | Data source | Data source |